Publication | Closed Access

Real-World Data on Pembrolizumab for Pretreated Non-Small-Cell Lung Cancer: Clinical Outcome and Relevance of the Lung Immune Prognostic Index

Prognostic BiomarkersMedicineReal-world DataImmunologyPathologyImmune Checkpoint InhibitorBronchial NeoplasmCancer TreatmentClinical OutcomeOncologyRadiation OncologyLung CancerHealth Sciences